Status:
RECRUITING
Post-Operative Myocardial Incident & Atrial Fibrillation
Lead Sponsor:
University Hospital, Lille
Conditions:
Valve Heart Disease
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
To explore predictors of major cardio-vascular events after cardiac surgery and trans-catheter valve implantation with a specific interest in studying mechanisms linking pre-operative leukocyte, fat a...
Eligibility Criteria
Inclusion
- patients scheduled for cardiac surgery (coronary artery bypass graft surgery and/or valvular surgery) or transcatheter valve implantation
Exclusion
- pregnant woman
- urgent surgery or intervention
- not able to consent to the protocol
Key Trial Info
Start Date :
January 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03376165
Start Date
January 30 2018
End Date
January 1 2028
Last Update
February 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Cardiologie, CHU
Lille, France